Glucosamine and warfarin alert
Glucosamine is widely used for the symptoms of osteoarthritis. Recent reports have suggested that it may interact with warfarin and thus make blood less likely to clot. The mechanism for this is uncertain. However, Arthritis Australia recommends that patients on warfarin who are starting or stopping glucosamine should have their INR (blood clotting) checked regularly for the first month. Patients who are on stable doses of both are unlikely to have problems.
Prof. Graeme Jones
Arthritis Australia Medical Director
Discover more...
-
Arthritis Australia’s first interactive Parliamentary Summit on Better Care for Arthritis and Musculoskeletal Conditions
Arthritis Australia’s first interactive Parliamentary Summit on Better Care for Arthritis and Musculoskeletal Conditions on 22 August was attended by over 90 consumers, clinicians, researchers,...
-
Arthritis and musculoskeletal conditions affect 7 million Australians
Arthritis and musculoskeletal conditions affect almost 1 in 3 Australians 7 million voices | 7 million stories One in three, which is more than 7...
-
World Arthritis Day | 2024
World Arthritis Day 2024: Empowering Through Information October 12th marks World Arthritis Day, a global initiative to recognise the challenges faced by millions living with...
Sign up to Arthritis Insights
Regular updates, news and research findings delivered to your inbox:
